US Patent Issued to ALKAHEST on July 28 for "Methods of improving retina-associated disease outcome using CCR3-inhibitors" (American, Polish Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,301, issued on July 28, was assigned to ALKAHEST INC. (San Carlos, Calif.).

"Methods of improving retina-associated disease outcome using CCR3-inhibitors" was invented by Bartosz Sikorski (Bydgoszcz, Poland), Elizabeth W. Jeffords (San Carlos, Calif.), Erin McCaskill Newman (San Carlos, Calif.), Jessica A. Powell (San Carlos, Calif.) and Esther Rawner (San Carlos, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a method of reducing the frequency of administration of an anti-VEGF agent to a subject diagnosed with wet age-related macular degeneration. The method comprises administering a CCR3 inhibitory agent to the subje...